43 Pages Posted: 12 Sep 2016 Last revised: 2 Feb 2017
Date Written: September 7, 2016
Exploiting a hand-collected database with over 2100 firms during 1996-2014, I analyze the relationship between the presence of poison pills and firm value (Tobin’s Q). Consistent with earlier results, I document a strong negative association between pills and firm value cross-sectionally and within firm. However, I document that (a) all the within-firm association is driven by pill adoptions (and none by the dropping of pills); (b) all the drop in value associated with adoptions actually precedes the pills’ adoption; and (c) firms adopted their pill after experiencing sharp, largely temporary, drops in their operating performance. These results indicate that the ostensive negative effect of pills on firm value is due to reverse causality, and that prior analyses were incorrect in concluding that pills are harmful and using pills as indicators of “bad governance”. Moreover, the results call into question the usefulness of the dramatic drop in the incidence of pills that took place during the last decade due to the pressure of ISS and institutional investors.
Keywords: Corporate Governance; Law and Finance; Corporate Law; Mergers and Acquisitions; Poison Pills; Takeovers; Anti-Takeover Devices
JEL Classification: G32, G34, K22
Suggested Citation: Suggested Citation
Catan, Emiliano, The Insignificance of Clear-Day Poison Pills (September 7, 2016). NYU Law and Economics Research Paper No. 16-33. Available at SSRN: https://ssrn.com/abstract=2836223
The Law and Finance of Anti-Takeover Statutes
By Emiliano Catan and Marcel Kahan
Staggered Boards and Long-Term Firm Value, Revisited
By Martijn Cremers, Lubomir Litov, ...
Do Takeover Laws Matter? Evidence from Five Decades of Hostile Takeovers
By Matthew Cain, Stephen Mckeon, ...
Shareholder Decision Rights in Acquisitions: Evidence from Tender Offers
By Audra Boone, Brian Broughman, ...
Commission Gallagher's and Professor Grundfest's Wrongful Attack on the Shareholder Rights Project
Did Harvard Violate Federal Securities Law? The Campaign Against Classified Boards of Directors
By Daniel Gallagher and Joseph Grundfest
Information for Submitting Articles to Law Reviews & Journals
By Allen Rostron and Nancy Levit
M&A Contracts: Purposes, Types, Regulation, and Patterns of Practice
Preserving Director Primacy by Managing Shareholder Interventions